Steven Pittler, Ph.D., at the University of Alabama at Birmingham has sought to find modifier genes for the hereditary eye disorder retinitis pigmentosa type 59. After onset in one’s late teens, RP59 ...
Study supports favorable safety and tolerability profile and clinically meaningful functional and structural benefits in Stargardt disease ...
Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback